24.165.517 PROTOCOLS FOR USE OF TOPICAL MEDICATIONS
(1) Only those classes of topical medications approved for use by 37-24-108, MCA, and prescribed for the patient by a licensed medical practitioner with prescriptive authority, may be applied by a clinician to a patient.
(2) Each clinician must:
(a) understand the use of approved topical medications;
(b) read and understand the medication package inserts for indications, contraindications, and actions;
(c) consult the Physician's Desk Reference (PDR) when necessary; and
(d) maintain appropriate records of all topical medication(s) applied or administered. The records must:
(i) be included in the patient's chart;
(ii) verify proper labeling and packaging;
(iii) demonstrate purchase from a licensed Montana pharmacy; and
(iv) include a record of the written prescription specifying the topical medication to be applied and the method of application (direct application, phonophoresis, or iontophoresis).
(3) The following classes of topical medications are approved for use by the clinician:
(a) bactericidal agents (see ARM 24.165.523);
(b) debriding agents (see ARM 24.165.518);
(c) anesthetic agents (see ARM 24.165.519);
(d) anti-inflammatory agents (see ARM 24.165.520);
(e) antispasmodic agents (see ARM 24.165.521); and
(f) adrenocortico-steroids (see ARM 24.165.522).
(4) Occupational therapists working at facilities with different protocols for the use of topical medications may apply for board authorization to use the facility protocols. The board will not authorize the use of any topical medication not authorized by 37-24-108, MCA.
History: 37-24-201, 37-24-202, MCA; IMP, 37-24-108, 37-24-109, MCA; NEW, 2005 MAR p. 447, Eff. 4/1/05; AMD, 2019 MAR p. 1743, Eff. 10/5/19.